Allahabad HC rejects bail pleas of two accused in Phensedyl syrup case

Lucknow:  The Allahabad High Court on Wednesday rejected the bail pleas of two accused in an alleged illegal stocking and transportation of Phensedyl cough syrup case.

Justice Karunesh Singh Pawar of the Lucknow bench passed the order on separate bail applications filed by the two accused Vibhor Rana and Vishal Singh.

The court had earlier granted them interim bail on December 18. Following the rejection of their regular bail pleas, both accused will have to surrender.

Opposing the bail applications, Additional Advocate General Anoop Trivedi submitted that information had been received over several days that Phensedyl cough syrup and other drugs were being illegally stored for intoxicating purposes and transported to Bihar, Jharkhand, West Bengal, Assam and Bangladesh.

He told the court that on February 12, 2024, the Uttar Pradesh government constituted a joint team of the Special Task Force and the Food Safety and Drug Administration to probe the matter.

On April 8, 2024, the STF received specific inputs that a truck loaded with cough syrup was being transported from Transport Nagar in Lucknow to Cooch Behar in West Bengal.

The STF intercepted the truck on Sultanpur Road and seized 52 cartons of cough syrup. During questioning, the truck driver, Dharmendra Kumar, allegedly disclosed the involvement of Rana and Singh in the case.

Subsequently, the STF arrested Rana and his associates from Saharanpur on November 11, 2025, the AAG said, adding that there was ample evidence against the accused and they were not entitled to bail.

Authorities in Uttar Pradesh are also carrying out a wider probe into the alleged illegal stocking and trade of regulated codeine-based syrups within and outside the state, with officials estimating that the racket runs into hundreds of crores of rupees.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’